$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
LLY Becomes "Dominant" GLP-1 Winner, NVO Growth Turns Anemic
12:30pm, Thursday, 05'th Feb 2026
After Eli Lilly (LLY) posted earnings that outshined Novo Nordisk's (NVO) decelerating growth, Scott Zari feels comfortable calling Eli Lilly the dominant winner in the weight loss drug race. While he
Novo Nordisk Accuses Hims & Hers of ‘Illegal Mass Compounding' Over Cheaper Wegovy Version
12:30pm, Thursday, 05'th Feb 2026
Hims & Hers said it would begin offering copies of Wegovy for an introductory price of $49 for the first month with a five-month plan.
Hims & Hers launches compounded semaglutide pill as lower-cost weight loss option
12:09pm, Thursday, 05'th Feb 2026
Hims & Hers (NYSE:HIMS) has announced the launch of a compounded semaglutide pill designed for weight loss, providing an alternative to Novo Nordisk (NYSE:NVO)'s Wegovy. The oral treatment uses the sa
Novo Nordisk CEO: Hims' $49 compounded Wegovy pill a 'waste' of money
11:38am, Thursday, 05'th Feb 2026
Novo Nordisk CEO Mike Doustdar was in a meeting with investors on Thursday discussing the company's tough recent outlook when one interrupted him with shock news: U.S. telehealth firm Hims and Hers He
Novo Nordisk to take legal action against Hims & Hers for Wegovy compounding
11:11am, Thursday, 05'th Feb 2026
Novo Nordisk said on Thursday it would take legal action against Hims & Hers after the online telehealth company said it will begin offering compounded copies of the Danish group's Wegovy pill at an i
Hims & Hers launch of compounded $49 Wegovy pill pummels Novo Nordisk's shares
10:56am, Thursday, 05'th Feb 2026
The compounded pill is less expensive than the oral version of Wegovy, which costs $149 to get started.
Why Eli Lilly Stock Just Dropped
10:48am, Thursday, 05'th Feb 2026
Hims and Hers has a GLP-1 weight loss pill -- and it's the cheapest one out there.
Novo Nordisk issues statement on illegal mass compounding and deceptive advertising by Hims & Hers
10:46am, Thursday, 05'th Feb 2026
Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 – Novo Nordisk today issued the following statement regarding the announcement by Hims & Hers that they will unlawfully mass-market an unapprov
VIEW Hims and Hers Health's compounded Wegovy pill offering fuels market jitters
10:06am, Thursday, 05'th Feb 2026
Hims & Hers said it would begin offering compounded versions of Novo Nordisk's Wegovy pill at an introductory price of $49 per month.
Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill
09:36am, Thursday, 05'th Feb 2026
Online telehealth company Hims & Hers will launch a copy of the newly launched Wegovy pill for $49, far less than the $149 Novo sells the branded pill for. Novo Nordisk and chief rival Eli Lilly stock
The Metabolic Split: Why Eli Lilly Soars as Novo Stumbles
09:34am, Thursday, 05'th Feb 2026
The first week of February 2026 will be remembered as the day the pharmaceutical sector's most famous partnership officially dissolved. For years, Eli Lilly and Company NYSE: LLY and Novo Nordisk A/S
Exclusive: Hims and Hers Health launches copy of Wegovy pill at $49
08:33am, Thursday, 05'th Feb 2026
Online telehealth company Hims and Hers Health will begin offering copies of Novo Nordisk's new Wegovy pill at an introductory price of $49 per month, the company said Thursday, about $100 less than t
First Look: AI shock hits software, Bitcoin breaks $70K, Disney names new CEO
07:38am, Thursday, 05'th Feb 2026
Stock News Bezos backs Post amid sweeping cuts: Amazon (AMZN) founder Jeff Bezos' Washington Post slashed roughly a third of staff and eliminated its Sports dep
Hims & Hers launches compounded semaglutide pill as lower-cost weight loss option
07:08am, Thursday, 05'th Feb 2026
Hims & Hers (NYSE:HIMS) has announced the launch of a compounded semaglutide pill designed for weight loss, providing an alternative to Novo Nordisk...
Novo Nordisk A/S (NOVO:CA) Q4 2025 Earnings Call Transcript
02:40am, Thursday, 05'th Feb 2026
Novo Nordisk A/S (NOVO:CA) Q4 2025 Earnings Call Transcript
Sign In
Buy NVO